Annual ROE
-20.82%
+41.62%+66.66%
31 March 2024
Summary:
Acasti Pharma annual return on equity is currently -20.82%, with the most recent change of +41.62% (+66.66%) on 31 March 2024. During the last 3 years, it has risen by +36.51% (+63.68%). ACST annual ROE is now -343.92% below its all-time high of -4.69%, reached on 28 February 2015.ACST ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-19.19%
-1.06%-5.85%
30 September 2024
Summary:
Acasti Pharma quarterly return on equity is currently -19.19%, with the most recent change of -1.06% (-5.85%) on 30 September 2024. Over the past year, it has increased by +35.34% (+64.81%). ACST quarterly ROE is now -105.39% below its all-time high of 356.13%, reached on 28 February 2011.ACST Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +66.7% | +64.8% |
3 y3 years | +63.7% | -8.6% |
5 y5 years | +95.4% | +98.1% |
ACST ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -129.6% | +66.7% | -89.1% | +67.4% |
5 y | 5 years | -129.6% | +95.4% | -180.1% | +98.1% |
alltime | all time | -343.9% | +95.4% | -105.4% | +98.1% |
Acasti Pharma ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -19.19%(+5.8%) |
June 2024 | - | -18.13%(-9.3%) |
Mar 2024 | -20.82%(-66.7%) | -19.99%(-66.0%) |
Dec 2023 | - | -58.88%(+8.0%) |
Sept 2023 | - | -54.53%(+6.9%) |
June 2023 | - | -51.00%(+11.0%) |
Mar 2023 | -62.44%(+588.4%) | -45.96%(+172.9%) |
Dec 2022 | - | -16.84%(+4.1%) |
Sept 2022 | - | -16.17%(+57.8%) |
June 2022 | - | -10.25%(+1.0%) |
Mar 2022 | -9.07%(-84.2%) | -10.15%(-26.6%) |
Dec 2021 | - | -13.83%(-21.7%) |
Sept 2021 | - | -17.67%(-65.0%) |
June 2021 | - | -50.46%(-41.4%) |
Mar 2021 | -57.33%(-73.0%) | -86.10%(-459.2%) |
Dec 2020 | - | 23.97%(-120.4%) |
Sept 2020 | - | -117.43%(-77.1%) |
June 2020 | - | -513.91%(-16.3%) |
Mar 2020 | -212.26%(-53.1%) | -614.35%(-33.6%) |
Dec 2019 | - | -925.05%(-7.9%) |
Sept 2019 | - | -1004.50%(+40.3%) |
June 2019 | - | -715.75%(+20.8%) |
Mar 2019 | -452.14%(+207.4%) | -592.35%(+27.8%) |
Dec 2018 | - | -463.36%(-32.9%) |
Sept 2018 | - | -690.81%(+248.2%) |
June 2018 | - | -198.40%(+42.5%) |
Mar 2018 | -147.08%(+217.1%) | -139.20%(+57.7%) |
Dec 2017 | - | -88.27%(+44.8%) |
Sept 2017 | - | -60.95%(+27.2%) |
June 2017 | - | -47.91% |
Date | Annual | Quarterly |
---|---|---|
Mar 2017 | -46.39%(+132.1%) | - |
Nov 2016 | - | -40.04%(+11.8%) |
Aug 2016 | - | -35.81%(+23.6%) |
May 2016 | - | -28.97%(+44.6%) |
Feb 2016 | -19.99%(+326.2%) | -20.04%(-1.7%) |
Nov 2015 | - | -20.39%(+468.0%) |
Aug 2015 | - | -3.59%(-69.8%) |
May 2015 | - | -11.87%(+148.3%) |
Feb 2015 | -4.69%(-91.1%) | -4.78%(-5.3%) |
Nov 2014 | - | -5.05%(-82.7%) |
Aug 2014 | - | -29.11%(-12.3%) |
May 2014 | - | -33.20%(-44.6%) |
Feb 2014 | -52.96%(-5.4%) | -59.96%(-20.4%) |
Nov 2013 | - | -75.28%(+11.4%) |
Aug 2013 | - | -67.58%(+3.6%) |
May 2013 | - | -65.26%(+18.3%) |
Feb 2013 | -55.98%(-12.7%) | -55.15%(+6.2%) |
Nov 2012 | - | -51.92%(-12.2%) |
Aug 2012 | - | -59.12%(-5.3%) |
May 2012 | - | -62.41%(-6.2%) |
Feb 2012 | -64.15%(+2.7%) | -66.57%(-25.2%) |
Nov 2011 | - | -89.02%(+3.6%) |
Aug 2011 | - | -85.94%(-41.8%) |
May 2011 | - | -147.75%(-141.5%) |
Feb 2011 | -62.45%(+66.4%) | 356.13%(+112.6%) |
Nov 2010 | - | 167.52%(+63.2%) |
Aug 2010 | - | 102.64%(-35.4%) |
May 2010 | - | 158.83%(-138.1%) |
Feb 2010 | -37.54% | -417.17%(-1371.5%) |
Nov 2009 | - | 32.81% |
FAQ
- What is Acasti Pharma annual return on equity?
- What is the all time high annual ROE for Acasti Pharma?
- What is Acasti Pharma annual ROE year-on-year change?
- What is Acasti Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Acasti Pharma?
- What is Acasti Pharma quarterly ROE year-on-year change?
What is Acasti Pharma annual return on equity?
The current annual ROE of ACST is -20.82%
What is the all time high annual ROE for Acasti Pharma?
Acasti Pharma all-time high annual return on equity is -4.69%
What is Acasti Pharma annual ROE year-on-year change?
Over the past year, ACST annual return on equity has changed by +41.62% (+66.66%)
What is Acasti Pharma quarterly return on equity?
The current quarterly ROE of ACST is -19.19%
What is the all time high quarterly ROE for Acasti Pharma?
Acasti Pharma all-time high quarterly return on equity is 356.13%
What is Acasti Pharma quarterly ROE year-on-year change?
Over the past year, ACST quarterly return on equity has changed by +35.34% (+64.81%)